Harlow John B. Jr. — SEC insider filings

SEC reporting owner CIK 2095554. 5 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-12-08 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Larimar Therapeutics, Inc. (LRMR)President and COO31 leg · 17,800 sh · $49,918—2
Esperion Therapeutics, Inc. (ESPR)Chief Commercial Officer2——3

Insider filings — Harlow John B. Jr.

FiledFormIssuerReported transactionsSource
2026-11-124Larimar Therapeutics, Inc. (LRMR)Purchase (P): 17,800 @ $2.80EDGAR
2026-10-014Larimar Therapeutics, Inc. (LRMR)Grant/award (A): 50,000 @ $0 · Grant/award (A): 800,000 (derivative) @ $0EDGAR
2026-10-013Larimar Therapeutics, Inc. (LRMR)Holdings only — no transactions reportedEDGAR
2026-07-134Esperion Therapeutics, Inc. (ESPR)Disposition to issuer (D): 424,536EDGAR
2025-12-084Esperion Therapeutics, Inc. (ESPR)Grant/award (A): 424,536 @ $0 · Grant/award (A): 380,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2095554 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs